Early Access Program With Arimoclomol in US Patients With NPC
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Birmingham
Birmingham, Alabama, United States
Joy Dean, MDAvailable - Ucsf Benioff Children'S Hospital and Research Center/ Ucsf
Oakland, California, United States
Caroline Hastings, MDAvailable - Children'S Hospital of Orange County (choc)
Orange, California, United States
Raymond Wang, MDAvailable - Nicklaus Children'S Hospital
Miami, Florida, United States
Paula Schleifer, MDAvailable - Rush University Medical Center
Chicago, Illinois, United States
Elizabeth Berry-Kravis, MD, PhDKatherine J Friedmann, MDAvailable - Boston Childrens Hospital
Boston, Massachusetts, United States
Melinda Palma, MDOlaf Bodamer, MDAvailable - Mayo Clinic Children'S Center
Rochester, Minnesota, United States
Marc Patterson, MD, PhDAvailable - New York University School of Medicine
New York, New York, United States
Nicolas Abreu, MDAvailable - Cincinnati Children'S Hospital Medical Center (cch)
Cincinnati, Ohio, United States
Nancy Leslie, MDAvailable - Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Can Ficicioglu, MD, PhDAvailable - Upmc Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Damara Ortiz, MDAvailable - Dell Children'S Medical Center
Austin, Texas, United States
Kristina Julich, MDAvailable - Ut Health / Mcgovern Medical School; Division of Medical Genetics
Houston, Texas, United States
Paul Hillman, MDAvailable
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- —
- Last update posted
- 16 Aug 2024
- Registered enrollment
- —
- Registry id
- NCT04316637
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.